Another leukemia success

I reported previously (see here) on new Israeli treatments for Acute Myeloid Leukemia (AML). Now the Hebrew University of Jerusalem and US biotech BioTheryX are developing a single molecule that attacks multiple leukemia proteins simultaneously. Lab tests show a 50% success rate.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.